US · Healthcare

Ascentage Pharma Group International (AAPG)

Biotechnology

Ascentage Pharma Group International (AAPG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AAPG

P/E ratio

25.00

Ascentage Pharma Group International (AAPG) — FAQ

What is AAPG's P/E ratio?

The price-to-earnings (P/E) ratio for Ascentage Pharma Group International (AAPG) is 25.00 (data as of 2026-05-23).

Does Ascentage Pharma Group International pay a dividend?

Dividend yield is not available in the current snapshot for Ascentage Pharma Group International (AAPG). Check the MyAverix Finance app for the latest dividend data.

What sector is Ascentage Pharma Group International in?

Ascentage Pharma Group International (AAPG) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AAPG listed on?

AAPG is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)